1. Executive Summary 2. Introduction 2.1 Contract Manufacturing: An Overview 2.1.1 Healthcare CMOs 2.1.2 Healthcare CMOs Market Segments 2.1.3 Pharmaceutical CMOs Active Pharmaceutical Ingredients (API) Finished Dosage Formulations (FDF) 2.1.4 Medical CMOs 2.2 Pharmaceutical Outsourcing: An Overview 2.2.1 Pharmaceutical Outsourcing Market Segments 2.3 Pharmaceutical CMOs v/s CDMOs 3. Global Market Analysis 3.1 Global Healthcare CMO Market: An Analysis 3.1.1 Global Healthcare CMO Market by Value 3.1.2 Global Healthcare CMO Market by Segments (Medical Device CMO and Pharmaceutical CMO) 3.2 Global Medical Device CMO Market: An Analysis 3.2.1 Global Medical Device CMO Market by Value 3.3 Global Pharmaceutical CMO Market: An Analysis 3.3.1 Global Pharmaceutical CMO Market by Value 3.3.2 Global Pharmaceutical CMO Market by Region (US, European Union, China, India, Japan, Brazil, Russia and South Korea) 3.3.3 Global Pharmaceutical CMO Market by Segments (API, Finished Dosage Formulation and Other Services) 3.3.4 Global Active Pharmaceutical Ingredient CMO Market by Value 3.3.5 Global Finished Dosage Formulation CMO Market by Value 3.3.6 Global Other Pharmaceutical Services CMO Market by Value 3.4 Global Pharmaceutical CDMO Market: An Analysis 3.4.1 Global Pharmaceutical CDMO Market by Value 3.4.2 Global Pharmaceutical CDMO Market by Region (US, Europe, India, and China) 4. Regional Analysis 4.1 The US Pharmaceutical CDMO Market: An Analysis 4.1.1 The US Pharmaceutical CDMO Market by Value 4.2 Europe Pharmaceutical CDMO Market: An Analysis 4.2.1 Europe Pharmaceutical CDMO Market by Value 4.3 India Pharmaceutical CDMO Market: An Analysis 4.3.1 India Pharmaceutical CDMO Market by Value 4.4 China Pharmaceutical CDMO Market: An Analysis 4.4.1 China Pharmaceutical CDMO Market by Value 5. Competitive Landscape 5.1 Global Healthcare CMO Market Players Financial Comparison 6. Company Profile 6.1 Catalent Pharma Solutions Inc. 6.1.1 Business Overview 6.1.2 Financial Overview 6.1.3 Business Strategy 6.2 Recipharm 6.2.1 Business Overview 6.2.2 Financial Overview 6.2.3 Business Strategy 6.3 Aurobindo Pharma Limited 6.3.1 Business Overview 6.3.2 Financial Overview 6.3.3 Business Strategy 6.4 Boehringer Ingelheim 6.4.1 Business Overview 6.4.2 Financial Overview 6.4.3 Business Strategy List of Figures Figure 1: Healthcare CMOs Market Segments Figure 2: Pharmaceutical Outsourcing Market Segments Figure 3: Value Chain of a Drug Figure 4: Global Healthcare CMO Market by Value; 2012-2017 (US$ Billion) Figure 5: Global Healthcare CMO Market by Value; 2018-2022 (US$ Billion) Figure 6: Global Healthcare CMO Market by Segments; 2017 (Percentage, %) (Medical Device CMO and Pharmaceutical CMO) Figure 7: Global Medical Device CMO Market by Value; 2012-2017 (US$ Billion) Figure 8: Global Medical Device CMO Market by Value; 2018-2022 (US$ Billion) Figure 9: Global Pharmaceutical CMO Market by Value; 2012-2016 (US$ Billion) Figure 10: Global Pharmaceutical CMO Market by Value; 2018-2022 (US$ Billion) Figure 11: Global Pharmaceutical CMO Market by Region; 2017 (Percentage, %) (US, European Union, China, India, Japan, Brazil, Russia and South Korea) Figure 12: Global Pharmaceutical CMO Market by Segments; 2017 (Percentage, %) (API, Finished Dosage Formulation and Other Services) Figure 13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2018-2022 (US$ Billion) Figure 14: Global Finished Dosage Formulation CMO Market by Value; 2018-2022 (US$ Billion) Figure 15: Global Other Pharmaceutical Services CMO Market by Value; 2018-2022 (US$ Billion) Figure 16: Global Pharmaceutical CDMO Market by Value; 2012-2017 (US$ Billion Figure 17: Global Pharmaceutical CDMO Market by Value; 2018-2022 (US$ Billion) Figure 18: Global Pharmaceutical CDMO Market by Region; 2017 (Percentage, %) (US, Europe, India, and China) Figure 19: The US Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion) Figure 20: The US Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion) Figure 21: Europe Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion) Figure 22: Europe Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion) Figure 23: India Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion) Figure 24: India Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion) Figure 25: China Pharmaceutical CDMO Market by Value; 2012-2016 (US$ Billion) Figure 26: China Pharmaceutical CDMO Market by Value; 2017-2021 (US$ Billion) Figure 27: Catalent Revenue; 2013-2017 (US$ Billion) Figure 28: Catalent Revenue by Segments; 20162017 (Percentage, %) Figure 29: Recipharm Net Sales; 2013-2017 (US$ Million) Figure 30: Recipharm Net Sales by Segments; 2017 (Percentage, %) Figure 31: Recipharm Net Sales by Region; 2017 (Percentage, %) Figure 32: Aurobindo Revenues; 2013-2017 (US$ Billion) Figure 33: Aurobindo Revenue by Segments; 2017 (Percentage, %) Figure 34: Boehringher Ingelheim Net Sales; 2012-2016 (US$ Billion) Figure 35: Boehringher Ingelheim Net Sales by Geography; 2016 (Percentage, %) Figure 36: Boehringher Ingelheim Net Sales by Business; 2016 (Percentage, %) Table 1: Global Healthcare CMO Market Players Financial Comparison; 2016-2017